ITL Health Group (ITD):企業の財務・戦略的SWOT分析

◆英語タイトル:ITL Health Group (ITD) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY0910
◆発行会社(調査会社):GlobalData
◆発行日:2020年1月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ITL Health Group (ITD) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ITL Health Group (ITL), formerly known as ITL Ltd is a medical technology company that develops, manufactures and markets medical and surgical devices, biological safety sampling devices and procedure packs for human and animal healthcare markets. The company offers products for blood banks, hospitals and laboratories, besides customized procedure packs; standardized procedure packs; sterile components; and monitoring kits and accessories. It also offers OEM products and custom healthcare devices according to clients’ specifications. ITL has research and development and manufacturing facilities in Malaysia and Australia. It has marketing offices and subsidiaries in North America, Europe, Australia and Malaysia. ITL is headquartered in Victoria, Australia.

ITL Health Group Key Recent Developments

Jan 08,2019: Company to delist from the ASX around the 8th February 2019

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ITL Health Group – Key Facts
ITL Health Group – Key Employees
ITL Health Group – Key Employee Biographies
ITL Health Group – Major Products and Services
ITL Health Group – History
ITL Health Group – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ITL Health Group – Business Description
ITL Health Group – Corporate Strategy
ITL Health Group – SWOT Analysis
SWOT Analysis – Overview
ITL Health Group – Strengths
ITL Health Group – Weaknesses
ITL Health Group – Opportunities
ITL Health Group – Threats
ITL Health Group – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ITL Health Group, Medical Equipment, Deals By Year, 2014 to YTD 2020
ITL Health Group, Medical Equipment, Deals By Type, 2014 to YTD 2020
ITL Health Group, Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 08, 2019: Company to delist from the ASX around the 8th February 2019
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ITL Health Group, Key Facts
ITL Health Group, Key Employees
ITL Health Group, Key Employee Biographies
ITL Health Group, Major Products and Services
ITL Health Group, History
ITL Health Group, Other Locations
ITL Health Group, Subsidiaries
ITL Health Group, Key Competitors
ITL Health Group, Ratios based on current share price
ITL Health Group, Annual Ratios
ITL Health Group, Annual Ratios (Cont...1)
ITL Health Group, Annual Ratios (Cont...2)
ITL Health Group, Interim Ratios
ITL Health Group, Medical Equipment, Deals By Year, 2014 to YTD 2020
ITL Health Group, Medical Equipment, Deals By Type, 2014 to YTD 2020
ITL Health Group, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ITL Health Group, Performance Chart (2014 - 2018)
ITL Health Group, Ratio Charts
ITL Health Group, Medical Equipment, Deals By Year, 2014 to YTD 2020
ITL Health Group, Medical Equipment, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[ITL Health Group (ITD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eone Diagnomics Genome Center Co Ltd (245620):企業の製品パイプライン分析
    Summary Eone Diagnomics Genome Center Co Ltd (EDGC) develops genome analysis technology solutions. The company focuses on the development of clinical genomic products for non-invasive prenatal test; newborn genetic screening test, hereditary cancer prediction test, female cancer prediction test and …
  • Bajaj Allianz General Insurance Company Limited:企業の戦略・SWOT・財務情報
    Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Bajaj Allianz General Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Orica Ltd:企業の戦略・SWOT・財務分析
    Orica Ltd - Strategy, SWOT and Corporate Finance Report Summary Orica Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Vaccitech Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Vaccitech Ltd (Vaccitech) is a clinical stage company that focuses on the development of universal flu vaccines. The company is developing clinical programs for the treatment of influenza, prostate cancer, HBV, Middle East respiratory syndrome (MERS), shingles, human papillomavirus (HPV), an …
  • Calixar SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Calixar SAS (Calixar) is a provider of solutions to develop conformational antibodies. The company offers production, Solubilization, extraction, purification, stabilization and crystallization of functional membrane proteins and antigens. It offers technology to discover and validate the po …
  • MedicPen AB (MPEN):医療機器:M&Aディール及び事業提携情報
    Summary MedicPen AB (MedicPen) is a drug development company that manufactures, develops, and markets patented products. The company’s products include Medimi Pro and Medimi Smart. It also provides Medimi – MedicPen’s system for medication assistance. MedicPen offers automatic filling units for home …
  • Pro Petroleum Inc:企業の戦略的SWOT分析
    Pro Petroleum Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Goodfellow Inc. (GDL):企業の戦略的SWOT分析
    Goodfellow Inc. (GDL) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Polpharma SA:企業の戦略的SWOT分析
    Polpharma SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Darden Restaurants, Inc.:戦略・SWOT・企業財務分析
    Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report Summary Darden Restaurants, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • A123 Systems LLC:企業の戦略的SWOT分析
    A123 Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • AKB Rosbank:企業の戦略・SWOT・財務情報
    AKB Rosbank - Strategy, SWOT and Corporate Finance Report Summary AKB Rosbank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • VentriPoint Diagnostics Ltd-医療機器分野:企業M&A・提携分析
    Summary VentriPoint Diagnostics Ltd (Ventripoint) is a medical device company that manufactures and distributes diagnostic tools and monitoring devices for patients with heart diseases. The company offers ventripoint diagnostic system, which is a cardiovascular monitoring and measurement device. Its …
  • Natra S.A.:企業の戦略・SWOT・財務分析
    Natra S.A. - Strategy, SWOT and Corporate Finance Report Summary Natra S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • CHS Inc (CHSCP)-石油・ガス分野:企業M&A・提携分析
    Summary CHS Inc. (CHS) is an integrated agribusiness company, which provides grain, foods and energy resources to businesses and consumers. It is a cooperative owned by farmers and ranchers and their member cooperatives across the US. The company provides a broad range of products and services, from …
  • Axela Inc-医療機器分野:企業M&A・提携分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Bioton SA (BIO):企業の財務・戦略的SWOT分析
    Bioton SA (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Primeline Energy Holdings Inc (PEH):企業の財務・戦略的SWOT分析
    Summary Primeline Energy Holdings Inc (Primeline Energy) is an upstream company that explores oil and gas. The company acquires and explores crude oil and natural gas properties across China. It owns and operates exploration and development rights in two offshore blocks in the East China Sea. Primel …
  • Helomics Corp:医療機器:M&Aディール及び事業提携情報
    Summary Helomics Corp (Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報
    Summary Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation’s products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provide …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆